Kojic acid face wash is regulated in the United States as a cosmetic, not a drug, which means the FDA does not approve or review the formula before it goes to market. However, this does not mean there are no regulatory obligations — the FDA holds cosmetic brands responsible for ensuring their products are safe and properly labeled under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
Under MoCRA, cosmetic brands selling in the US must register their manufacturing facility and list each cosmetic product with the FDA. This is a relatively new requirement (phased in from 2023 onward) that many indie brands are still catching up on. Your private label manufacturer should be registered; if they're not, that's a compliance gap that falls on your brand as the responsible party.
For labeling, a US-market kojic acid face wash must include: a statement of identity (e.g., 'Brightening Face Wash'), net quantity of contents, name and address of the responsible distributor, ingredient list in INCI format in descending order of predominance, and any required warnings. Kojic acid should appear as 'Kojic Acid' in the ingredient list — this is its correct INCI name.
Kojic acid is not currently classified as a drug ingredient by the FDA for over-the-counter (OTC) use, which means you cannot make drug claims like 'treats melasma' or 'prescribed by dermatologists' without triggering drug regulations. Stick to cosmetic claims: 'brightens,' 'evens skin tone,' 'reduces the appearance of dark spots.'
In the EU, kojic acid has been under review by the SCCS and is subject to more restrictive guidance than in the US. As of the most recent SCCS opinion, a 1% concentration is the upper limit being discussed for leave-on products, and rinse-off products like face wash may have more latitude. Confirm current limits with your regulatory consultant before exporting to EU markets.
In Japan and South Korea, kojic acid has a long regulatory history as a quasi-drug ingredient for skin brightening. Korean OTC quasi-drug approval for kojic acid at specific concentrations is well established, which is partly why Korean co-manufacturers are experienced with it.
Ingredients in this answer: Kojic Acid
Read the full guide on Private Label Kojic Acid Face Wash Manufacturer Low MOQ →